Skip to content

European Psychiatry

ISSN 0924-9338

206 papers in the library · 407 citations · publishing 1992-2026

Papers

Sort Most recent Most cited

Cannabis use and outcome of recent onset psychosis

European Psychiatry June 1, 2005 Anton Grech, Jim van Os, Peter B. Jones et al.

AbstractPurposeTo test the hypothesis that recent onset psychotic patients who use cannabis will have psychotic symptoms that are more severe and more persistent than those who do not use cannabis.Subjects and methodsWe carried out a 4-year follow-up study of a cohort of 119 patients with recent onset of psychosis. The patients were divided into four groups according to duration of cannabis...

The relationship between personality and post traumatic stress disorder

European Psychiatry May 1, 2002 Farāmarz Sohrābi

Ibogaine is a plant-derived alkaloid and dissociative psychedelic that demonstrates anti-addictive properties with several substances of abuse, including alcohol. 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a naturally occurring psychedelic known to occasion potent mystical-type experiences and also demonstrates anti-addictive properties. The potential therapeutic effects of both compounds...

Subjective effects of MDMA (‘Ecstasy’) on human sexual function

European Psychiatry March 1, 2001 Z. Zemishlany, Dov Aizenberg, Abraham Weizman 70 citations

Abstract Sexual function following 3,4-Methylenedioxymethamphetamine (MDMA, or ‘Ecstasy’) consumption was subjectively evaluated in 35 healthy recreational users (20 men and 15 women, aged 21–48 years) with regard to four major domains of sexual activity: desire, erection (lubrication in women), orgasm and satisfaction. Desire and satisfaction were moderately to profoundly increased by MDMA in...

The effects of psychoactive drugs and neuroleptics on language in normal subjects and schizophrenic patients: a review

European Psychiatry December 1, 2000 F. Salomé, P Boyer, Michel Fayol 21 citations

The aim of this survey is to present an overview of research into psychopharmacology as regards the effects of different psychoactive drugs and neuroleptics (NL) on language in normal subjects and schizophrenic patients. Eighteen studies that have investigated the effects of different drugs (alcohol, amphetamines, secobarbital, L-dopa, psilocybin, ketamine, fenfluramine) and neuroleptics...

Agony and ecstasy: a review of MDMA effects and toxicity

European Psychiatry August 1, 2000 C. Burgess, Alan O'Donohoe, Michael Gill 108 citations

Summary Background Background – Ecstasy is a recreational drug with an anecdotal reputation for safety. However, reports of adverse effects and fatalities have increased in the medical and popular press. Methods Method – Literature search and review. Results Results – Acute Ecstasy toxicity does not appear to be due to overdose and cannot be solely attributed to the nature of the usual ambient...

Is “cannabis psychosis” a distinct category?

European Psychiatry 1992 Graham Thornicroft, Graham Meadows, Pierluigi Politi 24 citations

Summary Forty-five cases of psychotic patients with admission urinalysis positive for cannabis were compared with psychotic controls without evidence of cannabis use. Cases and controls were matched for age, sex and year of admission, and were compared for socio-demographic data, circumstances of admission, diagnosis, and symptoms at admission. Three differences were found: cases were more...